Mirati, Revance price follow-ons

Mirati Therapeutics Inc. (NASDAQ:MRTX) and Revance Therapeutics Inc. (NASDAQ:RVNC) have each raised $100 million in follow-ons.

Mirati priced 1.6 million shares at $62

Read the full 228 word article

User Sign In